These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

579 related items for PubMed ID: 20034339

  • 1. Juvenile-onset clinically amyopathic dermatomyositis: an overview of recent progress in diagnosis and management.
    Walling HW, Gerami P, Sontheimer RD.
    Paediatr Drugs; 2010; 12(1):23-34. PubMed ID: 20034339
    [Abstract] [Full Text] [Related]

  • 2. A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis siné myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies.
    Gerami P, Schope JM, McDonald L, Walling HW, Sontheimer RD.
    J Am Acad Dermatol; 2006 Apr; 54(4):597-613. PubMed ID: 16546580
    [Abstract] [Full Text] [Related]

  • 3. Respiratory symptoms as initial manifestations of interstitial lung disease in clinically amyopathic juvenile dermatomyositis: a case report with literature review.
    Xia J, Jiang G, Jin T, Shen Q, Ma Y, Wang L, Qian L.
    BMC Pediatr; 2021 Nov 03; 21(1):488. PubMed ID: 34732158
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Lung infection or inflammation-a puzzling case of MDA-5 associated juvenile dermatomyositis.
    Vuppala A, Sondhi M, Umer S.
    Pediatr Rheumatol Online J; 2023 Dec 20; 21(1):147. PubMed ID: 38124190
    [Abstract] [Full Text] [Related]

  • 6. A systematic review of juvenile-onset clinically amyopathic dermatomyositis.
    Gerami P, Walling HW, Lewis J, Doughty L, Sontheimer RD.
    Br J Dermatol; 2007 Oct 20; 157(4):637-44. PubMed ID: 17596148
    [Abstract] [Full Text] [Related]

  • 7. Clinical characteristics and management of clinically amyopathic juvenile dermatomyositis across four academic centers.
    Bradley F, Bayer ML, Co DO, Chiu Y, Huber AM, Ahmad RC, Baris HE, Oberle EJ, Kim S.
    Pediatr Dermatol; 2021 Mar 20; 38(2):413-419. PubMed ID: 33438772
    [Abstract] [Full Text] [Related]

  • 8. Juvenile dermatomyositis associated with autoantibodies to small ubiquitin-like modifier activating enzyme: a report of 4 cases from North India and a review of literature.
    Vignesh P, Barman P, Basu S, Mondal S, Ishran B, Kumrah R, Dod A, Garg R, Rawat A, Singh S.
    Immunol Res; 2023 Feb 20; 71(1):112-120. PubMed ID: 36278969
    [Abstract] [Full Text] [Related]

  • 9. [Juvenile amyopathic dermatomyositis and calcinosis].
    Escorial Briso-Montiano M, Solís Sánchez P, Baeza Velasco M, Alonso Rubio A, de Gregorio Alvarez Z.
    An Pediatr (Barc); 2005 Mar 20; 62(3):286-8. PubMed ID: 15737292
    [Abstract] [Full Text] [Related]

  • 10. Features distinguishing clinically amyopathic juvenile dermatomyositis from juvenile dermatomyositis.
    Mamyrova G, Kishi T, Targoff IN, Ehrlich A, Curiel RV, Rider LG, Childhood Myositis Heterogeneity Collaborative Study Group.
    Rheumatology (Oxford); 2018 Nov 01; 57(11):1956-1963. PubMed ID: 30016492
    [Abstract] [Full Text] [Related]

  • 11. The arthritis of inflammatory childhood myositis syndromes.
    Tse S, Lubelsky S, Gordon M, Al Mayouf SM, Babyn PS, Laxer RM, Silverman ED, Schneider R, Feldman BM.
    J Rheumatol; 2001 Jan 01; 28(1):192-7. PubMed ID: 11196524
    [Abstract] [Full Text] [Related]

  • 12. Juvenile dermatomyositis: a tertiary center experience.
    Barut K, Aydin PO, Adrovic A, Sahin S, Kasapcopur O.
    Clin Rheumatol; 2017 Feb 01; 36(2):361-366. PubMed ID: 28058540
    [Abstract] [Full Text] [Related]

  • 13. Aggressive management of juvenile dermatomyositis results in improved outcome and decreased incidence of calcinosis.
    Fisler RE, Liang MG, Fuhlbrigge RC, Yalcindag A, Sundel RP.
    J Am Acad Dermatol; 2002 Oct 01; 47(4):505-11. PubMed ID: 12271292
    [Abstract] [Full Text] [Related]

  • 14. Current management of juvenile dermatomyositis in Germany and Austria: an online survey of pediatric rheumatologists and pediatric neurologists.
    Hinze CH, Speth F, Oommen PT, Haas JP.
    Pediatr Rheumatol Online J; 2018 Jun 20; 16(1):38. PubMed ID: 29925381
    [Abstract] [Full Text] [Related]

  • 15. Use of Janus kinase inhibitors in dermatomyositis: a systematic literature review.
    Paik JJ, Lubin G, Gromatzky A, Mudd PN, Ponda MP, Christopher-Stine L.
    Clin Exp Rheumatol; 2023 Mar 20; 41(2):348-358. PubMed ID: 35766013
    [Abstract] [Full Text] [Related]

  • 16. Treatment challenges in clinically amyopathic dermatomyositis: A case series and review of new therapeutic options for skin involvement.
    Rodríguez-Tejero A, López-Espadafor B, Montero-Vílchez T, Sánchez-Díaz M, Arias-Santiago S, Molina-Leyva A.
    Dermatol Ther; 2021 May 20; 34(3):e14942. PubMed ID: 33719170
    [Abstract] [Full Text] [Related]

  • 17. Amyopathic dermatomyositis or dermatomyositis-like skin disease: retrospective review of 16 cases with amyopathic dermatomyositis.
    Cao H, Parikh TN, Zheng J.
    Clin Rheumatol; 2009 Aug 20; 28(8):979-84. PubMed ID: 19294477
    [Abstract] [Full Text] [Related]

  • 18. How Often are Pediatric Patients with Clinically Amyopathic Dermatomyositis Truly Amyopathic?
    Oberle EJ, Bayer ML, Chiu YE, Co DO.
    Pediatr Dermatol; 2017 Jan 20; 34(1):50-57. PubMed ID: 27813167
    [Abstract] [Full Text] [Related]

  • 19. Idiopathic Inflammatory Myopathies.
    Balan S, Madan S.
    Indian J Pediatr; 2024 Oct 20; 91(10):1041-1048. PubMed ID: 37919486
    [Abstract] [Full Text] [Related]

  • 20. Successful Treatment of Rapidly Progressive Interstitial Lung Disease in Juvenile Dermatomyositis.
    Ciaglia K, Ghawji M, Caraballo M, Sloan E.
    Pediatrics; 2024 Mar 01; 153(3):. PubMed ID: 38361479
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.